RPG Investment Advisory’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20
Closed -$8K 240
2021
Q3
$8K Hold
20
﹤0.01% 234
2021
Q2
$5K Sell
20
-25
-56% -$4.47K ﹤0.01% 276
2021
Q1
$6K Hold
45
﹤0.01% 265
2020
Q4
$5K Hold
45
﹤0.01% 261
2020
Q3
$3K Hold
45
﹤0.01% 281
2020
Q2
$3K Buy
+45
New +$2.46K ﹤0.01% 291

Other funds holding MRNA

RPG Investment Advisory's MRNA Position: Q4 2021 in Review

RPG Investment Advisory sold out of Moderna (MRNA) in Q4 2021, closing a stake of 20 shares — an estimated $8K sold.

RPG Investment Advisory first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $8K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • RPG Investment Advisory reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • RPG Investment Advisory sold 20 Moderna shares in Q4 2021, an estimated $8K.
  • RPG Investment Advisory first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • RPG Investment Advisory's Moderna position peaked at $8K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on RPG Investment Advisory's 13F filing for Q4 2021, filed 28 Jan 2022.